Coltene Holding AGXSWX:CLTN +4.59%69 ROC (Joel Greenblatt) % is 25.06% as of Dec. 2025, which is 4% above its 10-year median of 24.20. GuruFocus rates XSWX:CLTN with a GF Score™ of 69/100 and a GF Value™ of CHF55.14 (Fairly Valued). The stock has 4 warning signs investors should review. Among 840 Medical Devices & Instruments companies, Coltene Holding AG ranks better than 69.05% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Coltene Holding AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 25.06%.
The historical rank and industry rank for Coltene Holding AG's ROC (Joel Greenblatt) % or its related term are showing as below:
XSWX:CLTN'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 13.62 Med: 24.2 Max: 35.54
Current: 18.88
During the past 13 years, Coltene Holding AG's highest ROC (Joel Greenblatt) % was 35.54%. The lowest was 13.62%. And the median was 24.20%.
XSWX:CLTN's ROC (Joel Greenblatt) % is ranked better than 69.05% of 840
companies
in the Medical Devices & Instruments industry
Industry Median: 4.035
vs XSWX:CLTN: 18.88
Coltene Holding AG's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -5.10% per year.
Coltene Holding AG (XSWX:CLTN) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Coltene Holding AG ROC (Joel Greenblatt) % Related Terms
Coltene Holding AG ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Coltene Holding AG's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:CLTN vs ISRG, BDX, MDLN: ROC (Joel Greenblatt) % Comparison
For the Medical Instruments & Supplies subindustry, Coltene Holding AG's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Coltene Holding AG ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Coltene Holding AG's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Coltene Holding AG's ROC (Joel Greenblatt) % falls into.
Coltene Holding AG ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 25.06% mean?
Coltene Holding AG (XSWX:CLTN) has a ROC (Joel Greenblatt) % of 25.06% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Coltene Holding AG and its competitors. This is near median its historical median of 24.20. Over the past decade, Coltene Holding AG's ROC (Joel Greenblatt) % has ranged from 13.62 to 35.54. According to the industry distribution chart, Coltene Holding AG ranks #260 out of 840 companies in the Medical Devices & Instruments industry, placing it in the top 31%.
Is Coltene Holding AG's ROC (Joel Greenblatt) % too high?
Coltene Holding AG's current ROC (Joel Greenblatt) % of 25.06% is near median its 10-year median of 24.20. Over the past 10 years, this metric has ranged from a low of 13.62 to a high of 35.54. The Medical Devices & Instruments industry median ROC (Joel Greenblatt) % is 4.04. Coltene Holding AG's value of 25.06% is 521.1% above this industry median. Based on the distribution chart, Coltene Holding AG ranks #260 out of 840 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Coltene Holding AG has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Coltene Holding AG's ROC (Joel Greenblatt) % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Coltene Holding AG ranks #260 out of 840 companies for ROC (Joel Greenblatt) %. This puts Coltene Holding AG in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 4.04. Coltene Holding AG's value of 25.06% is 521.1% above this benchmark. Historically, Coltene Holding AG's own ROC (Joel Greenblatt) % has ranged from 13.62 to 35.54 over the past decade. While the company's 10-year median is 24.20 vs. the industry median of 4.04, Coltene Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 4.04, based on 840 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Coltene Holding AG's current ROC (Joel Greenblatt) % of 25.06% is 521.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Coltene Holding AG and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 4.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Coltene Holding AG's current ROC (Joel Greenblatt) % is 25.06%, which is near median its own 10-year median of 24.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coltene Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Coltene Holding AG (XSWX:CLTN) is currently considered Fairly Valued. The stock's GF Value™ is CHF55.14, compared to a current price of CHF52.40 — trading 5% below its estimated fair value. The current ROC (Joel Greenblatt) % is 25.06%, which is near median its 10-year median of 24.20 and 521.1% above the Medical Devices & Instruments industry median of 4.04. Coltene Holding AG's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Coltene Holding AG (XSWX:CLTN), the current ROC (Joel Greenblatt) % is 25.06% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Coltene Holding AG (XSWX:CLTN) Overvalued in 2026?
Based on GuruFocus' analysis, Coltene Holding AG stock appears to be undervalued.
The current stock price of CHF52.40 is trading 5% below its estimated GF Value™ of CHF55.14.
GuruFocus considers Coltene Holding AG to be Fairly Valued.
Key valuation signals for XSWX:CLTN:
ROC (Joel Greenblatt) %: 25.06% (near median its 10-year median of 24.20)
GF Value™: CHF55.14 vs. price of CHF52.40 (5% below fair value)
Industry Position: 521.1% above the Medical Devices & Instruments median (#260 of 840)
No single metric tells the full story. See the XSWX:CLTN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Coltene Holding AG is a manufacturer and distributor of consumables and small devices for dental practices, dental service organisations (DSOs), dental clinics and laboratories, as well as for non-dental niches (e.g., clinics for ophthalmology or podiatry). The Group develops, manufactures, and sells mainly via distribution channels a broad and comprehensive range of disposables, tools, and equipment for dentists and dental laboratories. Geographically, it operates in EMEA, North America, Latin America, and Asia/Oceania, with maximum from North America.
69GF Score
Get the complete analysis for XSWX:CLTN
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:CLTN has been successfully added to your 
